文献速递甲状腺与浅表头颈USPETCT

基于ACR甲状腺影像报告和数据系统对18F-氟脱氧葡萄糖高摄取甲状腺结节的风险分层

Risk Stratification of 18F-Fluorodeoxyglucose-Avid Thyroid Nodules Based on ACR Thyroid Imaging Reporting and Data System.
PubMed 文献 · J Am Coll Radiol · 2020-10-31

回顾性纳入2010年1月1日至2018年11月19日间行超声引导下细针穿刺且穿刺前1年内行PET/CT的166例患者共170个甲状腺结节,按ACR TI-RADS分层评估FDG高摄取结节的恶性风险;151个有明确良恶性组织学结果的结节中52个(34.4%)为恶性,TR1至TR5恶性风险分别为0%、16.7%、13.2%、23.7%、68.1%,均高于已发表TI-RADS研究中的相应比例,超声低怀疑结节恶性风险13.3%(6/45)显著低于高怀疑结节43.4%(46/106,P < .001)。

要点

  • FDG高摄取甲状腺结节中71%(121/170)为TR4和TR5,恶性风险高于一般TI-RADS人群。
  • FDG高摄取结节各TI-RADS类别恶性风险均高于已发表TI-RADS研究:TR2 16.7% vs 1.5%,TR5 68.1% vs 35.0%。
  • 超声低怀疑结节恶性风险13.3%(6/45)显著低于高怀疑结节43.4%(46/106,P < .001)。

核心结论

  • FDG高摄取甲状腺结节多数为TR4和TR5,其恶性风险高于一般TI-RADS人群。
  • ACR TI-RADS有助于对FDG高摄取结节进行风险分层,超声低怀疑结节恶性风险显著低于高怀疑结节(13.3% vs 43.4%,P < .001)。

研究设计与样本

  • 回顾性研究,纳入2010年1月1日至2018年11月19日间行超声引导下FNA且FNA前1年内行PET/CT的患者。
  • 共170个结节(166例患者,65男、101女,年龄60.2 ± 14.3岁),其中151个有明确良性或恶性组织学结果。
  • PET图像由阅片者评估最大标准化摄取值和结节位置,超声特征及TI-RADS类别由三名放射科医生判定,并查阅病历获取组织学结果。

诊断标准与关键数值

  • 151个结节中52个恶性,总恶性风险34.4%。
  • FDG高摄取结节各TI-RADS类别恶性风险:TR1 0%(1个结节,已发表TI-RADS研究为0.3%)、TR2 16.7%(6个结节,已发表研究为1.5%)、TR3 13.2%(38个结节,已发表研究为4.8%)、TR4 23.7%(59个结节,已发表研究为9.1%)、TR5 68.1%(47个结节,已发表研究为35.0%)。
  • 超声低怀疑结节恶性风险13.3%(6/45),高怀疑结节43.4%(46/106),差异有统计学意义(P < .001)。

临床应用与阅片要点

  • 对FDG高摄取甲状腺结节可按ACR TI-RADS类别进行风险分层,TR4和TR5占多数且恶性风险高于一般TI-RADS人群。
  • 超声低怀疑结节(TR1-TR3)恶性风险13.3%(6/45),高怀疑结节(TR4-TR5)恶性风险43.4%(46/106),两者差异有统计学意义(P < .001)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Fine needle aspiration (FNA) of thyroid nodules is often requested based on 18F-fluorodeoxyglucose (FDG) uptake regardless of sonographic features. The purpose of this study is to determine the risk of malignancy in FDG-avid thyroid nodules when stratified according to the ACR Thyroid Imaging Reporting and Data System (TI-RADS).

METHODS: This retrospective study included patients who underwent ultrasound-guided FNA between January 1, 2010, and November 19, 2018, and PET/CT within 1 year before the FNA. In all, 170 nodules in 166 patients (65 men, 101 women, age 60.2 ± 14.3 years) were eligible for inclusion, of which 151 had a clearly benign or malignant histology. PET images were reviewed for maximum standardized uptake value and nodule location. Sonographic features and TI-RADS category were determined by three radiologists. Patient charts were reviewed for histology. Statistical analyses included risk of malignancy in FDG-avid nodules within each TI-RADS category.

RESULTS: Of the 151 nodules, 52 were malignant (34.4%). Malignancy risk was 0% in 1 TR1 nodule (compared with 0.3% in the published TI-RADS study), 16.7% in 6 TR2 nodules (compared with 1.5%), 13.2% in 38 TR3 nodules (compared with 4.8%), 23.7% in 59 TR4 nodules (compared with 9.1%), and 68.1% in 47 TR5 nodules (compared with 35.0%).

DISCUSSION: The majority (71%, 121 of 170) of FDG-avid thyroid nodules are TR4 and TR5, with rates of malignancy greater than those in the general TI-RADS population. ACR TI-RADS is helpful in stratification of FDG-avid nodules; the risk of malignancy in sonographically low-suspicion nodules (13.3%, 6 of 45) is significantly lower than high-suspicion nodules (43.4%, 46 of 106, P < .001).

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Felder GJ, Naeem M, Shady W, et al. Risk Stratification of 18F-Fluorodeoxyglucose-Avid Thyroid Nodules Based on ACR Thyroid Imaging Reporting and Data System. J Am Coll Radiol. 2020. PMID: 33137296. doi:10.1016/j.jacr.2020.08.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。